Loading...

Intracellular Staining Permeabilization Wash Buffer (10X) Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL DKK559
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  2. Kim S, et al. 2020. Development. 147:00:00. PubMed
  3. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  4. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  5. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  6. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  7. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  8. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  9. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  10. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  11. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  12. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  13. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  14. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  15. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  16. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  17. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  18. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  19. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  20. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  21. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  22. Chan L, et al. 2022. Cells. 12: . PubMed
  23. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  24. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  25. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  26. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  27. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  28. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  29. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  30. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  31. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  32. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  33. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  34. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  35. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  36. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  37. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  38. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  39. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  40. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  41. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  42. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  43. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  44. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  45. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  46. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  47. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  48. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  49. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  50. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  51. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  52. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  53. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  54. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  55. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  56. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  57. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  58. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  59. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  60. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  61. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  62. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  63. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  64. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  65. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  66. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  67. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  68. Stewart CA, et al. 2020. bioRxiv. . PubMed
  69. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  70. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  71. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  72. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  73. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  74. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  75. Poli V, et al. 2021. iScience. 24:103256. PubMed
  76. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  77. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  78. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  79. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  80. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  81. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  82. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  83. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  84. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  85. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  86. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  87. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  88. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  89. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  90. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  91. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  92. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  93. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  94. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  95. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  96. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  97. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  98. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  99. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  100. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  101. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  102. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  103. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  104. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  105. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  106. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  107. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  108. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  109. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  110. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  111. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  112. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  113. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  114. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  115. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  116. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  117. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  118. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  119. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  120. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  121. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  122. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  123. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  124. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  125. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  126. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  127. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  128. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  129. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  130. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  131. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  132. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  133. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  134. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  135. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  136. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  139. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  140. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  141. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  142. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  143. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  144. Kim S, et al. 2020. Development. . PubMed
  145. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  146. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  147. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  148. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  149. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  150. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  151. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  152. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  153. Ma K, et al. 2022. iScience. 25:104347. PubMed
  154. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  155. Lau H, et al. 2020. Islets. 41:12. PubMed
  156. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  157. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  158. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  159. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  160. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  161. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  162. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  163. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  164. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  165. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  166. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  167. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  168. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  169. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  170. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  171. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  172. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  173. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  174. Lee G, et al. 2021. Viruses. 13: . PubMed
  175. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  176. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  177. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  178. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  179. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  180. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  181. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  182. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  183. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  184. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  185. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  186. Su Y, et al. 2020. Cell. 1479:183. PubMed
  187. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  188. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  189. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  190. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  191. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  192. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  193. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  194. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  195. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  196. Wang X, et al. 2022. Elife. 11:. PubMed
  197. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  198. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  199. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  205. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  206. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  207. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  208. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  209. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  210. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  211. Kim S, et al. 2020. Development. 147:00:00. PubMed
  212. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  213. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  214. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  215. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  216. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  217. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  218. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  219. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  220. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  221. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  222. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  223. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  224. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  225. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  226. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  227. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  228. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  229. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  230. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  231. Chan L, et al. 2022. Cells. 12: . PubMed
  232. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  233. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  234. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  235. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  236. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  237. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  238. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  239. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  240. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  241. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  242. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  243. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  244. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  245. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  246. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  247. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  248. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  249. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  250. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  251. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  252. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  253. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  254. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  255. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  256. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  257. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  258. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  259. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  260. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  261. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  262. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  263. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  264. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  265. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  266. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  267. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  268. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  269. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  270. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  271. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  272. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  273. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  274. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  275. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  276. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  277. Stewart CA, et al. 2020. bioRxiv. . PubMed
  278. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  279. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  280. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  281. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  282. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  283. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  284. Poli V, et al. 2021. iScience. 24:103256. PubMed
  285. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  286. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  287. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  288. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  289. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  290. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  291. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  292. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  293. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  294. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  295. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  296. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  297. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  298. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  299. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  300. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  301. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  302. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  303. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  304. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  305. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  306. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  307. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  308. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  309. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  310. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  311. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  312. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  313. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  314. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  315. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  316. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  317. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  318. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  319. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  320. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  321. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  322. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  323. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  324. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  325. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  326. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  327. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  328. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  329. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  330. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  331. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  332. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  333. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  334. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  335. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  336. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  337. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  338. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  339. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  340. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  341. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  342. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  343. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  344. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  345. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  346. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  347. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  348. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  349. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  350. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  351. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  352. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  353. Kim S, et al. 2020. Development. . PubMed
  354. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  355. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  356. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  357. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  358. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  359. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  360. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  361. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  362. Ma K, et al. 2022. iScience. 25:104347. PubMed
  363. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  364. Lau H, et al. 2020. Islets. 41:12. PubMed
  365. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  366. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  367. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  368. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  369. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  370. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  371. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  372. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  373. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  374. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  375. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  376. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  377. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  378. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  379. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  380. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  381. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  382. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  383. Lee G, et al. 2021. Viruses. 13: . PubMed
  384. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  385. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  386. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  387. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  388. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  389. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  390. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  391. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  392. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  393. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  394. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  395. Su Y, et al. 2020. Cell. 1479:183. PubMed
  396. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  397. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  398. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  399. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  400. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  401. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  402. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  403. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  404. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  405. Wang X, et al. 2022. Elife. 11:. PubMed
  406. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  407. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  408. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  409. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  410. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  411. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  412. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  413. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  414. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  415. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  416. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  417. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  418. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08/26/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL DKK559
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  2. Kim S, et al. 2020. Development. 147:00:00. PubMed
  3. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  4. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  5. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  6. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  7. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  8. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  9. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  10. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  11. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  12. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  13. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  14. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  15. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  16. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  17. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  18. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  19. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  20. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  21. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  22. Chan L, et al. 2022. Cells. 12: . PubMed
  23. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  24. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  25. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  26. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  27. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  28. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  29. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  30. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  31. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  32. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  33. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  34. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  35. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  36. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  37. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  38. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  39. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  40. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  41. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  42. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  43. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  44. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  45. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  46. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  47. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  48. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  49. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  50. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  51. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  52. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  53. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  54. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  55. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  56. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  57. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  58. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  59. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  60. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  61. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  62. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  63. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  64. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  65. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  66. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  67. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  68. Stewart CA, et al. 2020. bioRxiv. . PubMed
  69. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  70. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  71. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  72. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  73. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  74. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  75. Poli V, et al. 2021. iScience. 24:103256. PubMed
  76. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  77. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  78. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  79. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  80. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  81. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  82. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  83. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  84. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  85. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  86. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  87. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  88. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  89. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  90. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  91. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  92. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  93. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  94. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  95. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  96. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  97. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  98. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  99. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  100. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  101. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  102. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  103. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  104. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  105. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  106. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  107. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  108. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  109. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  110. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  111. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  112. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  113. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  114. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  115. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  116. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  117. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  118. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  119. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  120. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  121. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  122. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  123. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  124. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  125. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  126. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  127. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  128. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  129. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  130. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  131. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  132. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  133. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  134. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  135. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  136. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  139. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  140. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  141. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  142. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  143. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  144. Kim S, et al. 2020. Development. . PubMed
  145. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  146. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  147. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  148. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  149. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  150. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  151. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  152. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  153. Ma K, et al. 2022. iScience. 25:104347. PubMed
  154. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  155. Lau H, et al. 2020. Islets. 41:12. PubMed
  156. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  157. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  158. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  159. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  160. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  161. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  162. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  163. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  164. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  165. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  166. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  167. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  168. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  169. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  170. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  171. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  172. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  173. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  174. Lee G, et al. 2021. Viruses. 13: . PubMed
  175. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  176. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  177. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  178. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  179. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  180. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  181. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  182. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  183. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  184. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  185. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  186. Su Y, et al. 2020. Cell. 1479:183. PubMed
  187. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  188. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  189. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  190. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  191. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  192. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  193. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  194. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  195. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  196. Wang X, et al. 2022. Elife. 11:. PubMed
  197. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  198. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  199. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  205. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  206. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  207. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  208. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  209. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  210. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  211. Kim S, et al. 2020. Development. 147:00:00. PubMed
  212. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  213. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  214. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  215. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  216. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  217. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  218. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  219. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  220. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  221. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  222. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  223. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  224. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  225. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  226. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  227. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  228. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  229. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  230. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  231. Chan L, et al. 2022. Cells. 12: . PubMed
  232. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  233. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  234. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  235. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  236. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  237. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  238. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  239. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  240. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  241. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  242. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  243. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  244. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  245. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  246. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  247. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  248. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  249. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  250. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  251. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  252. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  253. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  254. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  255. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  256. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  257. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  258. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  259. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  260. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  261. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  262. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  263. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  264. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  265. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  266. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  267. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  268. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  269. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  270. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  271. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  272. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  273. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  274. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  275. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  276. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  277. Stewart CA, et al. 2020. bioRxiv. . PubMed
  278. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  279. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  280. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  281. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  282. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  283. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  284. Poli V, et al. 2021. iScience. 24:103256. PubMed
  285. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  286. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  287. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  288. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  289. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  290. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  291. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  292. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  293. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  294. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  295. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  296. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  297. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  298. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  299. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  300. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  301. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  302. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  303. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  304. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  305. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  306. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  307. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  308. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  309. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  310. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  311. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  312. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  313. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  314. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  315. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  316. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  317. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  318. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  319. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  320. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  321. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  322. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  323. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  324. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  325. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  326. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  327. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  328. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  329. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  330. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  331. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  332. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  333. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  334. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  335. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  336. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  337. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  338. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  339. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  340. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  341. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  342. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  343. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  344. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  345. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  346. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  347. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  348. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  349. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  350. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  351. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  352. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  353. Kim S, et al. 2020. Development. . PubMed
  354. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  355. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  356. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  357. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  358. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  359. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  360. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  361. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  362. Ma K, et al. 2022. iScience. 25:104347. PubMed
  363. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  364. Lau H, et al. 2020. Islets. 41:12. PubMed
  365. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  366. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  367. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  368. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  369. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  370. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  371. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  372. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  373. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  374. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  375. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  376. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  377. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  378. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  379. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  380. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  381. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  382. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  383. Lee G, et al. 2021. Viruses. 13: . PubMed
  384. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  385. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  386. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  387. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  388. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  389. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  390. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  391. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  392. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  393. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  394. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  395. Su Y, et al. 2020. Cell. 1479:183. PubMed
  396. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  397. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  398. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  399. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  400. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  401. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  402. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  403. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  404. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  405. Wang X, et al. 2022. Elife. 11:. PubMed
  406. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  407. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  408. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  409. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  410. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  411. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  412. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  413. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  414. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  415. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  416. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  417. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  418. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 3    Revision Date: 08/26/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account